Linde Pays $425 Million to Agree With Its Critics
Records on the top line, a restructuring charge in the middle, and a fourth-quarter guide that refuses to assume the recovery it keeps forecasting.
LIN · Earnings Call · 2026-10-29
Linde Pays $425 Million to Agree With Its Critics
The apology came with an invoice
Three months ago Linde told shareholders its results "were not up to the expectation of our owners." On Thursday it put a number on that sentence: “we recorded a $425 million restructuring charge to better align our cost base and portfolio with market conditions” — Sanjiv Lamba, Chief Executive Officer · 2026-10-29. Roughly half is severance, "particularly in lower growth regions"; the balance is portfolio and asset actions concentrated in Lincare. That this was coming should not have surprised anyone. The prior call telegraphed it plainly — “We will likely look to take some cost actions this quarter, depending on the size... more to come on that” — Matthew J. White, Chief Financial Officer · 2026-07-31, Matt White said in July, promising colour on the October call. He delivered the colour: payback at "the higher 2-year end," full run-rate benefit in the second half of 2027. What management did not deliver was acceleration. Q3 was a record quarter — $9.4 billion of sales, $2.8 billion of operating profit, $4.59 of EPS, all quarterly highs — and yet “Operating margin of 29.4% fell 30 basis points from prior year, but was flat excluding cost pass-through” — Matthew White, Chief Financial Officer · 2026-10-29. Records, and a flat margin. That is the shape of this report.Lincare gets an exit sign — sort of
The most consequential line was structural rather than financial. Lincare, the U.S. home care business that has been the drag on the whole company, moves into the Global Other segment and reports directly to the CFO — as much a governance signal as an accounting one. The company's single highest-ranked keyword this quarter is strategic options, and it is not boilerplate: management has been circling this decision for well over a year. In July: “we are also evaluating what the strategic options for this business are” — Sanjiv Lamba, Chief Executive Officer · 2026-07-31. A year before that it was "the challenges at Lincare are not new." Nothing has been sold, and management explicitly cannot assure a transaction exists. But it invoked the GIST precedent — a business moved to Global Other, stripped of dedicated oversight, eventually sold. The mechanical consequences matter more near-term than the strategic ones. Lincare is a ~2% EPS drag year-to-date and pulls roughly $2.3 billion of annualised sales out of the Americas denominator — which conveniently makes Americas pricing look hotter. Matt was unusually candid about that: removing it means "by default, you will see more elevated pricing and more prominent recovery in Americas."Price is the new product
The genuinely fresh operating theme is a shift from pricing to inflation to pricing against a specific, localised cost shock. Americas price came in at +6%, of which roughly 2 points was catch-up for North American power and distribution costs; the underlying run rate is around 4%. That is a different animal from the "globally weighted CPI" script Linde has recited for years, and it shows up as cost pass-through optics in the margin table and as explicit pricing actions across almost every industrial reporter this week, from VMC to OI to MDLZ. This is now a sector-wide inflation-recovery cycle rather than a Linde idiosyncrasy. Management's own framing: “I feel very good about the 4% run rate on the underlying organic” — Matthew White, Chief Financial Officer · 2026-10-29 — with the honest caveat that recovery is dilutive to the 35% Americas margin. Behind it sits inflationary momentum that Sanjiv Lamba says is building across regions, including, for the first time in many quarters, positive inflation in China.What is actually working
Electronics (+15%) and chemicals & energy (+12%) carried the quarter. Electronics has roughly $2 billion of projects under construction in the U.S., Korea and China, and management is explicit that gas intensity climbs with each node — 15% growth against the 9-11% industry growth it has cited. Chemicals & energy is a U.S. Gulf Coast story: complex refiners needing hydrogen to process heavier, higher-sulphur crude as the Middle East conflict reshuffles feedstock advantage. Helium is the third leg, where global pricing is rising to cover dislocation costs and Qatar is expected back to only ~75% of production. Worth flagging a divergence with the tape. The market has spent 90 days de-rating the short-cycle semi hardware complex — High bandwidth memory, co-packaged optics and high-performance compute sit among the worst 90-day performers in the global theme set — while Linde sells two-to-three-year contracted atmospheric capacity into fabs on long-term contracts. That insulation is real, and helps explain why LIN is down only 2.4% over 90 days against a far uglier semi-cap tape. On the other side of the ledger, oil-linked themes are the 90-day advancers, with the barrel of oil theme positive across 24 of its 25 constituent tickers — precisely the Gulf Coast refining demand Linde is monetising.The guide, and the price of it
Q4 guidance of $4.40-4.50 (5-7% growth) implies roughly a 3% sequential decline: 1% FX, 1% normalisation of an elevated equity income, 1% seasonality and caution. “we didn't see a reason to take any bullish signals yet until we can kind of see how the rest of the economy plays out” — Matthew White, Chief Financial Officer · 2026-10-29. The full year holds at $17.82-17.92. Note that the 8-12% algorithm promised in May has still not been restored — “We know we need to get back to that 8% to 12% range excluding macro” — Matthew White, Chief Financial Officer · 2026-05-01 — and Lincare is the stated reason. Europe remains the anchor, and the language has hardened into resignation:That is the fifth or sixth consecutive quarter of European pessimism, which makes it consensus rather than insight — though it now arrives with a new data point: Chinese domestic EV purchases down 11-12% even as exports boom. The deeper tension is that Linde is spending like a growth company and earning like a mature one. In the latest filed quarter, capital expenditure reached $1.4 billion, up 14% year over year and up 85% over twelve months, while free cash flow margin has compressed to 9.0% from a peak above 20%. Meanwhile price to free cash flow sits near 48x and price to net income around 32x, against a net debt position of -$23.1 billion. That is a great deal of multiple for 5-7% growth.There is 0 catalyst. And I do not see the pragmatism that is needed across that whole European Union and the European community to take decisions that could get back industrial activity to a level where actually we start seeing some positive movement.